Antares Pharma, Inc. (ATRS)

EBITDA Margin

33.11%

TTM · Period ending:

ATRS logo

ATRS EBITDA Margin

Latest reported33.11%
ATRS TTM EBITDA Margin (-57.79% → 33.11%)
High-resolution chart · PNG

ATRS ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Antares Pharma, Inc. EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
33.1126%
37.514%
16.5872%
15.8963%
14.6901%
10.9192%
11.0045%
8.8018%
5.6518%
3.2931%
5.179%
2.3199%
-0.4829%
-1.756%
-19.3697%
-26.8081%
-25.5385%
-24.5514%
-27.0583%
-30.4271%
-37.3291%
-42.8519%
-49.2042%
-51.0464%
-39.7903%
-41.4253%
-53.3873%
-63.6954%
-107.0639%
-127.9259%
-129.4433%
-133.0707%
-118.279%
-96.7505%
-91.4266%
-77.6797%
-71.6533%
-49.5953%
-28.1978%
-20.1022%
-14.7204%
-25.6387%
-37.4402%
-42.0672%
-43.5704%
-46.0108%
-57.7954%
-72.3395%
-88.1952%
-113.4742%
-129.6379%
-152.3877%
-175.3593%
-219.1798%
-182.5889%
-172.8497%
-141.0229%
-70.9035%
-74.9248%
-71.101%
-88.2413%
-178.1665%
-271.5866%
-305.7618%
-346.8901%
-358.9036%
-380.5646%
-367.3446%
-313.4645%
-272.9134%
-262.9577%
-845.8618%
-849.006%
-832.9058%
-820.9573%
-295.9848%
-239.4258%
-238.0169%
-247.7466%
-243.994%
-235.1858%
-225.8339%
-255.5545%
-237.7155%
-251.0432%
-230.8891%
-125.2975%
-129.7418%
-151.1135%
-93.1139%
-143.3276%
-140.662%
-135.4076%
-188.0402%
-100.7929%
-92.2855%
-78.6753%
-71.178%
-72.7897%
-57.6773%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.